These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6356901)

  • 1. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
    Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
    Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
    Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial.
    Wallin JD; Wilson D; Winer N; Maronde RF; Michelson EL; Langford H; Maloy J; Poland M
    Am J Med; 1983 Oct; 75(4A):87-94. PubMed ID: 6356903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol in essential hypertension.
    Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
    J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
    Michelson EL; Frishman WH
    Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol in resistant hypertension.
    Hedstrand H
    Acta Med Scand Suppl; 1982; 665():125-8. PubMed ID: 6961758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
    Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
    Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
    Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension in the elderly with labetalol.
    Eisalo A; Virta P
    Acta Med Scand Suppl; 1982; 665():129-33. PubMed ID: 6961759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.